Home
June 2009 July 2009 August 2009
Su Mo Tu We Th Fr Sa
Week 27 1 2 3 4
Week 28 5 6 7 8 9 10 11
Week 29 12 13 14 15 16 17 18
Week 30 19 20 21 22 23 24 25
Week 31 26 27 28 29 30 31

Bladder Cancer
UroToday's Bladder Cancer section is a repository of the clinical publications, clinical trials and investigative science pertaining to the diagnosis and treatment of bladder cancer. Also available are conference coverage for all timely bladder cancer science, audio podcasts and downloadable slides from UroToday's slide library.
Online Urology & Urologic Oncology Journal
Please read about the UroToday International Journal; We welcome submissions year round and are committed to providing fast-tracked, peer reviewed publication.

Search    Display results per page
Results 301 - 350 of 1450
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>
Differential Expression of Survivin and its Splice Variants, Survivin-ΔEx3 and Survivin-2B, in Bladder Cancer - Abstract
Thursday, 19 February 2009
Department of Genetics, Faculty of Basic Sciences, Tarbiat Modares University, P.O. Box 14115-175 Tehran, Iran
read more

Does RNA Editing Play a Role in the Development of Urinary Bladder Cancer? - Abstract
Thursday, 19 February 2009
Department of Urology, The Chaim Sheba Medical Center, Tel-Ha'Shomer, Ramat-Gan, Affiliated to Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel
read more

Experimental Study on Inhibitory Effects of Histone Deacetylase Inhibitor MS-275 and TSA on Bladder Cancer Cells - Abstract
Wednesday, 18 February 2009
Department of Kidney Transplantation, Changzheng Hospital, Second Military Medical University, Shanghai, China
read more

A Panel of Angiogenic Factors for Early Bladder Cancer Detection: Enzyme Immunoassay and Western Blot - Abstract
Wednesday, 18 February 2009
Oncology Diagnostic Unit, Medical Biochemistry Department, Faculty of Medicine and Biochemistry Department, Ain Shams University, Cairo, Egypt
read more

Bioniche Phase II Bladder Cancer Trial Results Published in The Journal of Urology
Wednesday, 18 February 2009
BELLEVILLE, ON, CANADA (Press Release) - February 18, 2009
read more

Primary Osteosarcoma of the Urinary Bladder Following Cyclophosphamide Therapy for Systemic Lupus Erythematosus: A Case Report - Abstract
Tuesday, 17 February 2009
The association of systemic lupus erythematosus with malignancies is an uncommon occurrence.
read more

WUF 2009 - Lecture Series - High Risk Upper Tract TCC
Monday, 16 February 2009
VAIL, CO, USA - Presented by James McKiernan, MD at the 33rd Winter Urologic Forum - "State-of-the-Art in Urology" - January 23 - 28, 2009, Vail, Colorado, USA
Login to read more...

Metastatic Malignant Melanoma of the Urinary Bladder Presenting with Hematuria: A Case Report - Abstract
Monday, 16 February 2009
The Department of Urology, Keiyu Hospital
read more

Long-Term Outcome of Hand-Assisted Laparoscopic Nephroureterectomy for Pathologic T3 Upper Urinary Tract - Abstract
Monday, 16 February 2009
Division of Urology, Department of Surgery, Far-Eastern Memorial Hospital, Ban Ciao, Taipei, Taiwan
read more

Beyond the Abstract - MicroRNAs and Cancer: Current State and Future Perspectives in Urologic Oncology
Friday, 13 February 2009
BERKELEY, CA (UroToday.com) - The related review summarizes the current state of microRNA (miRNA) research in urology and gives an outlook on potential diagnostic and therapeutic value of miRNAs.
Login to read more...

Altered Antioxidant Status and Lipid Peroxidation in Indian Patients with Urothelial Bladder Carcinoma - Abstract
Friday, 13 February 2009
Department of Biochemistry, All India Institute of Medical Sciences, New Delhi, India
read more

Use of Double J Ureteral Stent as an Alternative to Prevent Ureteroileal Anastomosis Stricture in Orthotopic Bladder Substitution - Abstract
Friday, 13 February 2009
Service d'urologie, hôpital Cochin, groupe hospitalier Cochin St-Vincent-de-Paul, 27, rue du Faubourg-Saint-Jacques, 75014 Paris, France
read more

Transrectal Ultrasound as Diagnostic Tool for the Detection of Local Recurrence following Cystectomy and Urinary Diversion - Abstract
Friday, 13 February 2009
Department of Urology, University of Ulm, Ulm, Germany
read more

Urinary Tract Infections and Reduced Risk of Bladder Cancer in Los Angeles - Abstract
Friday, 13 February 2009
Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA 90089, USA
read more

Urinary Bladder Cancer Producing Granulocyte-Colony Stimulating Factor: A Case Report and Review of the Literature - Abstract
Friday, 13 February 2009
The Department of Urology, Mazda hospital, Hiroshima, Japan
read more

Expression of Angiogenesis Inhibitors in Human Bladder Cancer May Explain Rapid Metastatic Progression After Radical Cystectomy - Abstract
Friday, 13 February 2009
Clinic of Urology, Vitalicum(R); University of Frankfurt/Main, Frankfurt/Main, Germany
read more

Relationship Between Cysteinyl-Leukotriene-1 Receptor and Human Transitional Cell Carcinoma in Bladder - Abstract
Thursday, 12 February 2009
Department of Urology, Osaka City University Graduate School of Medicine, Osaka, Japan.
read more

Assessment in a Urological Department of Nurses' Workload for Neurological Patients - Abstract
Thursday, 12 February 2009
Service d'urologie, transplantation rénale et andrologie, CHU de Rangueil, TSA 50032, 31059 Toulouse cedex, France
read more

Friend or Foe? Role of Peroxisome Proliferator-Activated Receptor-Gamma in Human Bladder Cancer - Abstract
Wednesday, 11 February 2009
Department of Urology, University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA.
read more

Effect of Postcystectomy Infectious Complications on Cost, Length of Stay, and Mortality - Abstract
Wednesday, 11 February 2009
Department of Urology, University of California, San Francisco, Comprehensive Cancer Center, University of California, San Francisco, School of Medicine, San Francisco, California, USA.
read more

State of the Art and Advances in Radiotherapy for Bladder Cancer - Abstract
Wednesday, 11 February 2009
Département de radiothérapie, centre Antoine-Lacassagne, 33, avenue Valombrose, 06189 Nice cedex 2, France.
read more

Urodynamix, Motion Computing Team Up on RFID-enabled Diagnostic Device
Tuesday, 10 February 2009
VANCOUVER, BC, CANADA (Press Release) - Feb. 10, 2009
read more

Response of Bladder Carcinoma Cells to TRAIL and Antisense Oligonucleotide, Bcl-2 or Clusterin Treatments - Abstract
Tuesday, 10 February 2009
Department of Surgery, Cross Cancer Institute, University of Alberta, Edmonton, Alberta, Canada.
read more

The Updated EAU Guidelines on Muscle-Invasive and Metastatic Bladder Cancer - Abstract
Tuesday, 10 February 2009
Department of Urology, Eberhard-Karls-University Tuebingen, Tuebingen, Germany.
read more

Cytogenetic Analysis of False-Positive Mucosa by Photodynamic Diagnosis Using 5-Aminolevulinic Acid - Possible Existence of Premalignant Genomic Alterations Examined by in vitro Experiment - Abstract
Tuesday, 10 February 2009
Department of Urology, Graduate School of Medicine, Yamaguchi University, Ube, Japan.
read more

Sexual Function of Patients Under Surveillance for Bladder Cancer - Abstract
Monday, 09 February 2009
Department of Pathology, Erasmus MC Rotterdam, Rotterdam, the Netherlands.
read more

A Chemosensitivity Test to Individualize Intravesical Treatment for Non-Muscle-Invasive Bladder Cancer - Abstract
Monday, 09 February 2009
Departments of Experimental Medicine and Urology, 'Sapienza' University of Rome, Rome, Italy.
read more

Outcomes of Radical Nephroureterectomy: A Series from the Upper Tract Urothelial Carcinoma Collaboration - Abstract
Monday, 09 February 2009
Department of Urology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas.
read more

Thirty-Five Years of Noninvasive Bladder Carcinoma: A Plea for the Use of Papillary Intraurothelial Neoplasia as New Terminology - Abstract
Monday, 09 February 2009
Department of Pathology and Laboratory Medicine, University Health Network and Mount Sinai Hospital, University of Toronto, Ontario, Canada.
read more

Comparison of American Joint Committee on Cancer Pathologic Stage T3a Versus T3b Urothelial Carcinoma: Analysis of Patient Outcomes. - Abstract
Friday, 06 February 2009
Department of Urologic Surgery, Vanderbilt University Medical Center, Nashville, Tennessee.
read more

Understanding Bladder Cancer Death: Tumor Biology Versus Physician Practice - Abstract
Friday, 06 February 2009
Department of Urology, University of Michigan, Ann Arbor, Michigan.
read more

A Novel Algorithm to Improve Pathologic Stage Prediction of Clinically Organ-Confined Muscle-Invasive Bladder Cancer - Abstract
Friday, 06 February 2009
Institute of Urology, Rabin Medical Center, Beilinson Campus, Petach Tikva, Israel.
read more

Renal Sinus Myelolipoma Coexistent With Renal Pelvis Papillary Transitional Cell Carcinoma: A Case Report - Abstract
Friday, 06 February 2009
A unique case of renal sinus myelolipoma presenting as a mass coexistent with papillary transitional cell carcinoma is reported.
read more

Should All Patients with Non-Muscle-Invasive Bladder Cancer Receive Early Intravesical Chemotherapy after Transurethral Resection? The Results of a Prospective Randomised Multicentre Study - Abstract
Friday, 06 February 2009
Lund University Hospital, Lund, Sweden.
read more

The Results of Concurrent Chemo-Radiotherapy for Recurrence After Treatment with Bacillus Calmette-Guérin for Non-Muscle-Invasive Bladder Cancer: Is Immediate Cystectomy Always Necessary? - Abstract
Friday, 06 February 2009
Harvard Radiation Oncology Program, and Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
read more

Favourable Outcomes of Patients with Clinical Stage T3N0M0 Bladder Cancer Treated with Induction Low-Dose Chemo-Radiotherapy Plus Partial or Radical Cystectomy vs Immediate Radical Cystectomy: A Single-Institutional Retrospective Comparative Study - Abstract
Friday, 06 February 2009
Department of Urology, Tokyo Medical and Dental University, Graduate School, Tokyo, Japan.
read more

Intravesical Mycobacterial Cell Wall-DNA Complex in the Treatment of Carcinoma In Situ of the Bladder After Standard Intravesical Therapy Has Failed - Abstract
Thursday, 05 February 2009
Queen's University, Kingston, Ontario.
read more

Predictors of Upper Tract Urothelial Cell Carcinoma After Primary Bladder Cancer: A Population Based Analysis - Abstract
Thursday, 05 February 2009
Department of Urology, University of Washington School of Medicine, Seattle, Washington.
read more

Routine Perioperative Chemotherapy Instillation with Initial Bladder Tumor Resection: A Reconsideration of Economic Benefits - Abstract
Thursday, 05 February 2009
Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, Ohio.
read more

Quantitative Fluorescence in Situ Hybridization and its Ability to Predict Bladder Cancer Recurrence and Progression to Muscle Invasive Bladder Cancer - Abstract
Thursday, 05 February 2009
Departments of Laboratory Medicine and Pathology, Urology, and Biostatistics, Mayo Clinic and Foundation, Rochester, Minnesota.
read more

Beyond the Abstract - How to Combine the Molecular Profile With the Clinicopathological Profile of Urothelial Neoplastic Lesions
Wednesday, 04 February 2009
BERKELEY, CA (UroToday.com) - The background of this review paper was the question raised by the WHO Collaborating Center for Urologic Tumors: to what extent it is possible to reconcile current molecular-biological findings with the clinical pathology of bladder neoplasia?
Login to read more...

Is the Complication Rate of Radical Cystectomy Predictive of the Complication Rate of Other Urological Procedures? - Abstract
Wednesday, 04 February 2009
Departments of Urology and Epidemiology, University of California-San Francisco, San Francisco, California.
read more

The Impact of Lymphadenectomy and Lymph Node Metastasis on the Outcomes of Radical Cystectomy for Bladder Cancer - Abstract
Wednesday, 04 February 2009
Department of Urology, University of Munich, LMU, Campus Grosshadern, Munich, Germany.
read more

Carcinoma in situ of the Urinary Bladder: Review of Clinicopathologic Characteristics with an Emphasis on Aspects Related to Molecular Diagnostic Techniques and Prognosis - Abstract
Wednesday, 04 February 2009
Department of Pathology, Cedars Sinai Medical Center, Los Angeles, California, USA.
read more

Allium Introduces First-Ever Bladder-Neck Stent
Tuesday, 03 February 2009
CAESAREA, ISRAEL (Press Release) – February 3, 2009
read more

Indications, Extent, and Benefits of Pelvic Lymph Node Dissection for Patients with Bladder and Prostate Cancer - Abstract
Tuesday, 03 February 2009
Inselspital, Bern, Switzerland.
read more

Extended Lymph Node Dissection in Patients with Urothelial Cell Carcinoma of the Bladder: Can it Make a Difference? - Abstract
Tuesday, 03 February 2009
Department of Urology, Lund University Hospital, 221 85, Lund, Sweden.
read more

Profiling Bladder Cancer Organ Site-Specific Metastasis Identifies LAMC2 as a Novel Biomarker of Hematogenous Dissemination - Abstract
Tuesday, 03 February 2009
Department of Molecular Physiology and Biological Physics, University of Virginia Health System, Charlottesville, VA 22908, USA.
read more

Selenium and Risk of Bladder Cancer: A Population-Based Case-Control Study - Abstract
Monday, 02 February 2009
Department of Community and Family Medicine, Section of Biostatistics and Epidemiology, Dartmouth Medical School, 7927 Rubin Building, 1 Medical Center Drive, Lebanon, NH 03756, USA.
read more

Combined Ultrasmall Superparamagnetic Particles of Iron Oxide-Enhanced and Diffusion-Weighted Magnetic Resonance Imaging Reliably Detect Pelvic Lymph Node Metastases in Normal-Sized Nodes of Bladder and Prostate Cancer Patients - Abstract
Monday, 02 February 2009
University Hospital of Bern, Department of Radiology, Neuroradiology and Nuclear Medicine, Bern, Switzerland.
read more








Exclusive!

Interview on Clinical Practice Experience with NMP22

Meet the Expert

Meet the Expert - Mark S. Soloway

Meet the Expert - Ihor S. Sawczuk

Focus on Bladder Cancer

Focus on Bladder Cancer condenses a selection of compelling and relevant science - on topic and chosen by the UroToday.com editorial staff.



Urinary Bladder Cancer: Diffusion-Weighted MR Imaging--Accuracy for Diagnosing T Stage and Estimating Histologic Grade

- Beyond the Abstract

The Novel Use of Intravesical Docetaxel for the Treatment of Non-Muscle Invasive Bladder Cancer Refractory to BCG Therapy: A Single Institution Experience

- Editorial

Predictive Value of Telomerase Reverse Transcriptase Expression in Patients with High Risk Superficial Bladder Cancer Treated with Adjuvant BCG Immunotherapy

- Editorial

ImageTherapeutic Options in the Management of Intermediate-Risk Nonmuscle-Invasive Bladder Cancer

- BJUI Mini Reviews

Image

A Cost Comparison of the Diagnostic Modalities Used in the Detection of Urothelial Carcinoma in Patients Undergoing Evaluation for Hematuria

- UroToday International Journal

ImageTwo Centuries of Cystoscopy: The Development of Imaging, Instrumentation and Synergistic Technologies

- BJUI Mini Reviews

Clinical Outcome of Chemoradiotherapy for T1G3 Bladder Cancer

- Beyond the Abstract

Prognostic Significance of Nondiagnostic Molecular Changes in Urine Detected by UroVysion Fluorescence In Situ Hybridization During Surveillance for Bladder Cancer

- Editorial

Image

Utilization of the NMP22® BladderChek® Urine Test as an Adjunct to Atypical Cytology in the Detection of Bladder Cancer Recurrence

- UroToday International Journal

Radiation Therapy for Prostate Cancer Increases Subsequent Risk of Bladder and Rectal Cancer: A Population Based Cohort Study

- Editorial

Image

Long Term Clinical Outcome of a Phase I Trial of Intravesical Docetaxel in the Management of Superficial Bladder Cancer Refractory to Standard Intravesical Therapy

- UroToday International Journal

ImageInvestigation of Publication Bias Using the Model of p53 Accumulation in Bladder Cancer

- UroToday International Journal

Cultured Milk, Yogurt, and Dairy Intake in Relation to Bladder Cancer Risk in a Prospective Study of Swedish Women and Men

- Editorial

Adjuvant Methotrexate, Vinblastine, Adriamycin, and Cisplatin Chemotherapy has Potential to Prevent Recurrence of Bladder Tumors After Surgical Removal of Upper Urinary Tract Transitional Cell Carcinoma

- Editorial

Matrix Metalloproteinase Polymorphisms Are Associated with Bladder Cancer Invasiveness

- Editorial - Editor's Pick

Laparoscopic Radical Cystectomy for Cancer: Oncological Outcomes at up to 5 years

- Editorial - Editor's Pick

ImageBladder Cancer and the Aluminium Industry: A Review

- BJUI Mini Reviews

External Beam Radiation Therapy Followed by Interstitial Radiotherapy with Iridium-192 for Solitary Bladder Tumours: Results of 111 Treated Patients

- Beyond the Abstract

Bladder Tumor Markers: From Hematuria to Molecular Diagnostics - Where Do We Stand?

- Beyond the Abstract

Familial and Genetic Risk of Transitional Cell Carcinoma of the Urinary Tract

- Beyond the Abstract

Bladder-Sparing Therapy for Muscle-Infiltrating Bladder Cancer

- Beyond the Abstract

Detection of Bladder Cancer in Human Urine by Metabolomic Profiling Using High Performance Liquid Chromatography/Mass Spectrometry

- Beyond the Abstract

ImageInvasive T1 Bladder Cancer: Indications and Rationale for Radical Cystectomy

- BJUI Mini Reviews

Podcast - San Francisco Firefighters and Bladder Cancer Screening

- Podcast

ImagePredicting Survival After Radical Cystectomy for Bladder Cancer

- BJUI Mini Reviews







Bladder Cancer Screening

Improved Detection and Surveillance of Bladder Cancer Using a Point-of-Care NMP22 Assay

- by Mark S. Soloway, MD

Improving the Diagnosis of Bladder Cancer -Combining Cystoscopy with a Physician's Office Tumor Marker Test

- CME Training Program

Improved Detection of Bladder Cancer in Diagnosis and Surveillance Patients Using a Point-of-Care Proteomic Assay

- Barry Stein, MD on Improved Detection of Bladder Cancer in Diagnosis

Should We Screen for Bladder Cancer in a High Risk Population: A Cost per Life-Year Saved Analysis?

- Yair Lotan, MD on Screening for Bladder Cancer

Wisconsin Industrial Workers Might Be At Increased Risk For Bladder Cancer

- Giora Katz, MD Reports on Increased Risk for Bladder Cancer

Utility of NMP22 BladderCheck Point-Of-Care Assay In Evaluation Of Hematuria: A Multicenter Study

- Giora Katz, MD on the Utility of NMP22 Bladdercheck

Initial Diagnosis Of Bladder Cancer Using A Point-Of-Care Assay

- H. Barton Grossman, MD & the NMP22 Clinical Investigation Group




Bladder Cancer in Conferences


ImageAmerican Society of Clinical Oncology (ASCO) 2009 Annual Meeting

- View Bladder Cancer Session Highlights
ImageAmerican Urological Association (AUA) 2009 Annual Meeting

- View Bladder Cancer Session Highlights from the AUA 2009 Annual Meeting
Image10 Tips for Non-Muscle Invasive Bladder Cancer

- Lecture presented at WUF 2009 by David P. Wood, Jr., MD

ImageSociety of Urologic Oncology (SUO) 9th Annual Winter Meeting

- View Bladder Cancer Session Highlights

ImageRobot Assisted Radical Cystectomy: Is it Ready for Prime Time?

- Session Highlight from AUA Western Section 2008

ImageBladder Cancer Cytology and Markers in Diagnosis and Assessment

- Presentation from the 2008 AUA NY Meeting

Re-Staging Transurethral Resection: Who Benefits?

- Slide Presentation from the 2008 AUA NY Section Meeting

ImageNon-Muscle Invasive Transitional Cell Carcinoma

- Slide Presentation from the 2008 Masters in Urology Conference

American Society of Clinical Oncology 44th Annual Meeting

- Bladder Cancer Abstracts

The American Urological Association 2008 Annual Meeting

- Bladder Cancer Session Highlights

ImageEngineering and Urology Society 23rd Annual Meeting

- Bladder Cancer Abstracts

ImageEuropean Association of Urology 23rd Annual EAU Congress

- Bladder Cancer Session Highlights

 
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>
Results 301 - 350 of 1450

Member's Section

Login

Sign Up

Quick Search

Meet the Expert


All Experts


Featured Conference

Complete WUF 2009 Coverage

Media and Publisher

Advertising Rates
Reprints

Working with Industry

Case Studies
Sponsorship Opportunities

Bladder Cancer
Sponsored By